Australia markets closed

Chimerix, Inc. (CMRX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.9000-0.0392 (-4.17%)
At close: 04:00PM EDT
0.9000 0.00 (0.00%)
After hours: 07:25PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.9392
Open0.9206
Bid0.8702 x 100
Ask0.9543 x 100
Day's range0.9000 - 0.9400
52-week range0.7500 - 1.3000
Volume52,001
Avg. volume474,118
Market cap80.675M
Beta (5Y monthly)1.11
PE ratio (TTM)N/A
EPS (TTM)-0.9600
Earnings date31 Oct 2024 - 04 Nov 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est6.83
  • Simply Wall St.

    Here's Why We're Watching Chimerix's (NASDAQ:CMRX) Cash Burn Situation

    We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...

  • GlobeNewswire

    Chimerix to Present at H.C. Wainwright 26th Annual Global Investment Conference

    DURHAM, N.C., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that Mike Andriole, Chief Executive Officer, will present a corporate presentation at the H.C. Wainwright 26th Annual Global Investment Conference made available on Monday, September 9, 2024 at 7:00 a.m. ET. An audio webcast of the presentation will be avail

  • GlobeNewswire

    Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    DURHAM, N.C., Aug. 30, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on August 20, 2024, the Compensation Committee of Chimerix’s Board of Directors granted an inducement award to a new employee of non-statutory stock options to purchase up to a total of 150,000 shares of Chimerix’s common stock. The Compensation Committee of Chimerix’s Board of Directors approved the award as an inducement material to the new employee’s employment in accordance with Nasdaq Listing rule 5